PURA VIDA INVESTMENTS, LLC - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
PURA VIDA INVESTMENTS, LLC ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q4 2022$246,309
-40.8%
77,700
-44.5%
0.01%
-45.8%
Q3 2022$416,000
-49.1%
139,924
-47.8%
0.02%
-50.0%
Q2 2022$818,000
-82.2%
268,131
-21.0%
0.05%
-67.8%
Q1 2022$4,583,000
-25.8%
339,468
-28.4%
0.15%
-33.5%
Q4 2021$6,180,000474,3030.22%
Other shareholders
ATHIRA PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 714,763$2,265,7992.16%
Perceptive Advisors 4,797,278$15,207,3710.43%
Potomac Capital Management, Inc. 80,000$2540.30%
Bristlecone Advisors, LLC 696,629$2,208,3140.27%
TANG CAPITAL MANAGEMENT LLC 485,234$1,538,1920.22%
RA Capital Management 1,881,300$5,963,7210.12%
GSA CAPITAL PARTNERS LLP 270,989$8590.11%
PATHSTONE FAMILY OFFICE, LLC 3,631,080$8,182,6500.07%
Laird Norton Wetherby Trust Company, LLC 130,000$412,1000.06%
Forefront Analytics, LLC 22,350$70,8510.04%
View complete list of ATHIRA PHARMA INC shareholders